4
Changes in Ownership
Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-17-006529
Chairman and CEO bought 7,500 shares at an average $1.16 ($8,725)
From the SEC's structured data for this filing
Trades in this filing
SETH SANDESH · Chairman and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-06-15 | Purchase : show line 1 in the form | +2,500 | $1.17 | $2,925 | 37,500 | D |
| 2017-06-15 | Purchase : show line 2 in the form | +5,000 | $1.16 | $5,800 | 42,500 | D |
| Open-market purchases · 7,500 sh · avg $1.16 · $8,725 | ||||||
Loading xslF345X03/f4061517seth_actinium.xml…